Bob Dylan’s announcement final month that he had offered his huge songwriting catalog to Universal Music for a value estimated at greater than $300 million underscored what had been more and more clear over the previous two years: Song publishing rights are an more and more coveted asset class, attracting spectacular cash and loads of traders trying to money in.
This is finest embodied by Merck Mercuriadis, who heads the Hipgnosis Songs Fund, which has spent roughly $1.7 billion lately to amass the rights to over 57,000 songs. The emergence of Hipgnosis has helped flip the battle for tune catalogs into an arms race, one which exhibits no indicators of slowing down.
On this week’s Popcast, a interrogation of the present bull market in tune publishing, and an evaluation of its long-term viability.
Guest:
